Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature-Reference-Cited by-同舟云学术

Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature

Published:1998-03 Issue:3 Volume:138 Page:529-532
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:British Journal of Dermatology

Author:

Gupta ¹,Lynde ²,Lauzon ³,Mehlmauer ⁴,Braddock ⁵,Miller ⁶,Del Rosso ⁷,Shear ⁸

Affiliation:

1. Division of Dermatology, Department of Medicine, Sunnybrook Health Science Center and the University of Toronto, Toronto, Canada,

2. Division of Dermatology, Department of Medicine, Toronto Western Hospital and the University of Toronto, Toronto, Canada,

3. Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada,

4. Pasadena CA, U.S.A.,

5. Braddock Dermatology Clinic, Omaha, NB, U.S.A.,

6. Burlingame CA, U.S.A.,

7. Las Vegas Skin and Cancer Clinics, Las Vegas, NV, U.S.A.,

8. Divisions of Dermatology and Clinical Pharmacology, Department of Medicine and Pharmacology, Sunnybrook Health Science Center and the University of Toronto, Toronto, Canada

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2133.1998.02140.x

Reference17 articles.

1. 1 Sandoz Pharmaceuticals Corporation . US product monograph on terbinafine (Lamisil). East Hanover, NJ. Sandoz Pharmaceuticals Corporation, April 1996 .

2. Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study

3. A method for estimating the probability of adverse drug reactions

4. Psoriasis, Ultraviolet Light, and Chloroquine

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis;Antimicrobial Agents and Chemotherapy;2024-08-19

2. Viral Infections;Rook's Textbook of Dermatology;2024-03-19

3. Effectiveness and safety of oral terbinafine for dermatophyte distal subungual onychomycosis;Expert Opinion on Pharmacotherapy;2024-01-02

4. Severe drug eruption from oral terbinafine for mild onychomycosis—A case report from family practice and literature review: “Just an innocent little pill?”;SAGE Open Medical Case Reports;2024-01

5. Development of Solvent-Free Co-Ground Method to Produce Terbinafine Hydrochloride Cyclodextrin Binary Systems; Structural and In Vitro Characterizations;Pharmaceutics;2022-03-30